Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #international #pharma #jobs

Posted On Jan 7 2018 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #pharmaceutical #formulation #companies

Posted On Jan 7 2018 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


Sun joins dermatology rush with $230M DUSA buyout #mitsubishi #tanabe #pharma

Posted On Dec 24 2017 by

#dusa pharma # Sun joins dermatology rush with $230M DUSA buyout Dermatology is hot. Valeant Pharmaceuticals ($VRX) has been snapping up skin-remedy companies, including its recent $2.6 billion deal for Medicis. Novartis’ generics unit Sandoz agreed in May to buy U.S.-based Fougera Pharmaceuticals, to become the biggest player in dermatology generics. Now, India-based Sun Pharmaceutical is joining the party. It’s buying U.S. drugmaker DUSA Pharmaceuticals for about $230 million, or $8 per share, a 38% premium to yesterday’s closing price. The key prizes: DUSA’s Levulan combination therapy, used to treat non-hyperkeratotic actinic keratoses, and BLU-U, used to treat acne. “DUSA …


Sun Pharma to buy Dusa for $230 million #pharma #training

Posted On Dec 24 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #medical #sales #jobs

Posted On Dec 8 2017 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


DUSA – News and Analysis – DUSA Pharmaceuticals, Inc #jobs #in #pharmaceutical #industry

Posted On Dec 8 2017 by

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #pharmacia

Posted On Nov 29 2017 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #pharmaceutical #manufacturer

Posted On Nov 22 2017 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #astellas #pharma #europe

Posted On Nov 13 2017 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


Sun Pharma to buy Dusa for $230 million #jobs #in #pharmaceuticals

Posted On Sep 30 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …